醫科達（交易代碼：EKTAB）是全球領先的專注爲全身腫瘤和腦部疾病提供放(fàng)射治療解決方案的國際化公司，由瑞典卡羅林斯卡研究所已故的神經外(wài)科教授LarsLeksell于1972年創立，總部設在瑞典斯德哥爾摩，是瑞典商(shāng)會會員(yuán)之一(yī)。

        秉承“專注，爲生(shēng)命全力以赴”，醫科達通過醫療技術的持續創新，不斷引領行業發展的新高度，緻力于爲全球用戶提供精準、智能、高效的放(fàng)射治療解決方案和腫瘤信息管理系統，改善、延長及挽救患者生(shēng)命。在醫科達，有五分(fēn)之一(yī)的員(yuán)工(gōng)從事研發工(gōng)作。精準放(fàng)療領域，醫科達過去(qù)五年研發總投資(zī)達60億瑞典克朗。

        目前，醫科達的業務範圍涉及120多個國家和地區，先進技術和創新解決方案應用于全球6,000多家醫療機構，每天爲超過10萬名患者提供診斷和治療服務。醫科達提供放(fàng)射治療全系列解決方案，包括：腫瘤放(fàng)射治療系統(醫用直線加速器)、高場強磁共振放(fàng)療系統、立體(tǐ)定向神經外(wài)科解決方案、近距離(lí)放(fàng)射治療解決方案、MOSAIQ®腫瘤信息管理系統及Monaco®治療計劃系統、Elekta CareTM 全方位售後服務。

        其中(zhōng)高場強導磁共振放(fàng)療系統（Elekta Unity）是腫瘤治療領域的一(yī)大(dà)科技創舉，将診斷級高場強磁共振與精準放(fàng)療創新性地整合一(yī)起，開(kāi)啓腫瘤精準放(fàng)射治療的新篇章。目前，4台新設備已投入臨床使用，已賣出32台設備。醫科達預計其将成爲精準放(fàng)療的的新标杆，市場規模将在3,000至4,000台。 

        全球大(dà)趨勢影響着我(wǒ)們的發展，面對未來放(fàng)療市場的巨大(dà)需求，醫科達将專注核心業務、持續改善工(gōng)作流程與治療成果，同時提高整體(tǐ)治療水平、提升服務與二級市場，并繼續加大(dà)研發投入。 

        Elekta, a global leader in medical radiotherapy and neurosurgery, was incorporated in 1972 and headquartered in Stockholm, Sweden. Founded by the Swedish professor of neurosurgery who invented the first Gamma Knife in human history, it is an international company specializing in radiotherapy solutions for cancer care and brain disorders. Adhering to the philosophy of "Focus where it matters", Elekta continues to lead the industrial development through sustaining innovation in medical technology, and is committed to globally accessible, precise, intelligent and efficient radiation therapy solutions and oncology information management system to improve, prolong and save patients' lives. One-fifth of the employees of Elekta are engaged in research and development. Elekta has invested a total of SEK 6 billion in precision radiation medicine R&D in the past five years. At present, the company's business covers over 120 countries and regions, with advanced technologies and innovative solutions applied in over 6,000 medical institutions around the world, providing diagnosis and treatment services for over 100,000 patients every day.